• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Cho et al's "GLP-1 receptor agonist use is associated with increased rates of acne vulgaris diagnosis in non-diabetic obese women but not men: A retrospective cohort study".

作者信息

Thang Christopher J, Garate David, Sánchez-Feliciano Abizairie, Barbieri John S

机构信息

John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.

John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas.

出版信息

J Am Acad Dermatol. 2025 Sep;93(3):e121-e122. doi: 10.1016/j.jaad.2025.03.102. Epub 2025 May 30.

DOI:10.1016/j.jaad.2025.03.102
PMID:40451302
Abstract
摘要

相似文献

1
Response to Cho et al's "GLP-1 receptor agonist use is associated with increased rates of acne vulgaris diagnosis in non-diabetic obese women but not men: A retrospective cohort study".对赵等人的《胰高血糖素样肽-1受体激动剂的使用与非糖尿病肥胖女性而非男性寻常痤疮诊断率增加相关：一项回顾性队列研究》的回应
J Am Acad Dermatol. 2025 Sep;93(3):e121-e122. doi: 10.1016/j.jaad.2025.03.102. Epub 2025 May 30.
2
Response to Thang et al's "Response to Cho et al's 'GLP-1 receptor agonist use is associated with increased rates of acne vulgaris diagnosis in non-diabetic obese women but not men: A retrospective cohort study'".对唐等人《对赵等人〈胰高血糖素样肽-1受体激动剂的使用与非糖尿病肥胖女性而非男性寻常痤疮诊断率增加相关：一项回顾性队列研究〉的回应》的回应
J Am Acad Dermatol. 2025 Sep;93(3):e123-e124. doi: 10.1016/j.jaad.2025.04.085. Epub 2025 May 30.
3
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂（GLP-1 RAs）减肥效果的网状Meta分析的数量、质量及结果：一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
4
Minocycline for acne vulgaris: efficacy and safety.米诺环素治疗寻常痤疮：疗效与安全性。
Cochrane Database Syst Rev. 2003(1):CD002086. doi: 10.1002/14651858.CD002086.
5
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes.糖尿病患者中使用胰高血糖素样肽-1受体激动剂与意义未明的单克隆丙种球蛋白病进展为多发性骨髓瘤之间的关联。
JNCI Cancer Spectr. 2024 Nov 1;8(6). doi: 10.1093/jncics/pkae095.
6
Glucagon-Like Peptide-1 Receptor Agonist Medications Alter Outcomes of Spine Surgery: A Study Among Over 15,000 Patients.胰高血糖素样肽-1受体激动剂类药物改变脊柱手术结局：一项针对超过15000例患者的研究。
Spine (Phila Pa 1976). 2025 Jul 1;50(13):871-880. doi: 10.1097/BRS.0000000000005283. Epub 2025 Feb 3.
7
Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes.孕前使用胰高血糖素样肽-1受体激动剂与不良产科结局风险降低相关。
Am J Obstet Gynecol. 2025 Jan 21. doi: 10.1016/j.ajog.2025.01.019.
8
Perioperative Glucagon-Like Peptide-1 Agonist Use and Rates of Pseudarthrosis After Single-Level Lumbar Fusion: A Large Retrospective Cohort Study.围手术期使用胰高血糖素样肽-1激动剂与单节段腰椎融合术后假关节形成率：一项大型回顾性队列研究
Neurosurgery. 2024 Nov 26;97(1):91-97. doi: 10.1227/neu.0000000000003291.
9
Exendin(9-39)NH : Recommendations for clinical use based on a systematic literature review.Exendin(9-39)NH：基于系统文献回顾的临床应用建议。
Diabetes Obes Metab. 2021 Nov;23(11):2419-2436. doi: 10.1111/dom.14507. Epub 2021 Aug 23.
10
GLP-1 agonist use increases the incidence of adhesive capsulitis and odds of requiring operative management in type 2 diabetes patients: a matched propensity score analysis.胰高血糖素样肽-1激动剂的使用增加了2型糖尿病患者粘连性囊炎的发生率及需要手术治疗的几率：一项匹配倾向评分分析。
J Shoulder Elbow Surg. 2025 Aug;34(8):e656-e663. doi: 10.1016/j.jse.2024.11.041. Epub 2025 Jan 22.